Visceral analgesia: effects of xylazine, butorphanol, meperidine, and pentazocine in horses.

The study investigates the effects of several visceral painkillers – xylazine, butorphanol, meperidine, and pentazocine – on adult horses with artificially induced colic, focusing on their effects on pain relief, heart and respiratory rates, blood pressure and cardiac output. The result indicates that xylazine is most effective in relieving visceral pain and also lasts longest.

Research Methodology

• The study involved nine adult horses that were induced with colic. This was accomplished by inflating a balloon in each horse’s cecum (a pouch within the intestine).
• The researchers monitored the heart and respiratory rates, mean arterial blood pressure, and cardiac output of the animals before and after the balloon inflation.
• The four visceral analgesics – xylazine, butorphanol, meperidine, and pentazocine were administered to the horses. The research aimed to measure their effects on the cardiorespiratory indicators and their effectiveness in alleviating the visceral pain caused by the artificially induced colic.

Research Findings

• The induced colic caused increases in heart and respiratory rates, mean arterial blood pressure, and cardiac output in all the horses.
• Xylazine and butorphanol both caused a decrease in these cardiorespiratory reactions to cecal balloon inflation, indicating a beneficial effect on the heart and respiratory indicators.
• Meperidine and pentazocine, on the other hand, showed minimal effects on the cardiorespiratory changes caused by balloon inflation.
• Xylazine produced the most significant effect in terms of visceral pain reduction, making it the most effective analgesic among those tested in the study.
• Xylazine also had the longest lasting duration of analgesic activity estimated at approximately 90 minutes, followed by butorphanol (around 60 minutes), then meperidine and pentazocine (from 30 to 35 minutes).

Conclusion and Implications

• The research findings underpin the effectiveness of xylazine in managing visceral pain in horses, with added benefits on their cardiorespiratory response. This could mean that it could be a favourable choice for colic treatment in horses.
• Furthermore, the study highlights the importance of objective pain evaluation tests when measuring the effects of visceral analgesics. Such tests are crucial in accurately assessing the efficacy of drugs in managing visceral pain.